Christopher W. Krueger, Chief Business Officer at Ventyx Biosciences, Inc. (VTYX), sold 30,000 shares at $34.65 ($1.0M) on 2023-06-05, disclosed to the SEC on 2023-06-06.
Open-market sale of $1.0M VTYX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.31 | 12,883 | $442K | 42.9% |
| 2 | $34.31 | 12,883 | $442K | 42.9% |
| 3 | $34.65 | 2,117 | $73K | 7.1% |
| 4 | $34.65 | 2,117 | $73K | 7.1% |
| Total | $34.36 avg | 30,000 | $1.0M | 100% |
| Filing → |
| VTYX | SELL | 2023-10-04 | $869K | — | Filing → |
| VTYX | SELL | 2023-09-07 | $977K | — | Filing → |
| VTYX | SELL | 2023-08-04 | $1.1M | — | Filing → |